

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | immunoglobulin mediated immune response (GO:0016064) | 7.19885898 |
| 2 | B cell mediated immunity (GO:0019724) | 5.73489826 |
| 3 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 5.63834874 |
| 4 | interferon-gamma-mediated signaling pathway (GO:0060333) | 5.29858221 |
| 5 | regulation of antigen processing and presentation (GO:0002577) | 5.28199259 |
| 6 | positive regulation of antigen processing and presentation (GO:0002579) | 5.07721112 |
| 7 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.63585638 |
| 8 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.25078352 |
| 9 | cellular response to interferon-gamma (GO:0071346) | 4.24635429 |
| 10 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 4.22989384 |
| 11 | positive thymic T cell selection (GO:0045059) | 4.21037492 |
| 12 | neutrophil activation involved in immune response (GO:0002283) | 4.09390189 |
| 13 | production of molecular mediator of immune response (GO:0002440) | 4.07755408 |
| 14 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.06145250 |
| 15 | T-helper 1 type immune response (GO:0042088) | 4.05832788 |
| 16 | detection of bacterium (GO:0016045) | 3.91179487 |
| 17 | response to interferon-gamma (GO:0034341) | 3.87796844 |
| 18 | T cell costimulation (GO:0031295) | 3.86492909 |
| 19 | lymphocyte costimulation (GO:0031294) | 3.80804979 |
| 20 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 3.74272551 |
| 21 | detection of other organism (GO:0098543) | 3.70939379 |
| 22 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.61506430 |
| 23 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.59387060 |
| 24 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 3.55373150 |
| 25 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.54358853 |
| 26 | DNA deamination (GO:0045006) | 3.49995428 |
| 27 | B cell receptor signaling pathway (GO:0050853) | 3.43353978 |
| 28 | regulation of hypersensitivity (GO:0002883) | 3.40150178 |
| 29 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.38316717 |
| 30 | response to interferon-beta (GO:0035456) | 3.33976368 |
| 31 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.30722509 |
| 32 | mast cell activation (GO:0045576) | 3.30111218 |
| 33 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.24985459 |
| 34 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.24029784 |
| 35 | type I interferon signaling pathway (GO:0060337) | 3.20920790 |
| 36 | cellular response to type I interferon (GO:0071357) | 3.20920790 |
| 37 | response to type I interferon (GO:0034340) | 3.16753296 |
| 38 | defense response to protozoan (GO:0042832) | 3.14715121 |
| 39 | positive regulation of type 2 immune response (GO:0002830) | 3.10553160 |
| 40 | regulation of germinal center formation (GO:0002634) | 3.03746630 |
| 41 | response to protozoan (GO:0001562) | 3.01319850 |
| 42 | myeloid cell activation involved in immune response (GO:0002275) | 2.99626511 |
| 43 | regulation of mast cell activation (GO:0033003) | 2.99518677 |
| 44 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.98933099 |
| 45 | leukocyte degranulation (GO:0043299) | 2.98594724 |
| 46 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.92712478 |
| 47 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.90194177 |
| 48 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.88876480 |
| 49 | positive regulation of interferon-gamma production (GO:0032729) | 2.88822090 |
| 50 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.86967065 |
| 51 | positive regulation of mast cell degranulation (GO:0043306) | 2.86649412 |
| 52 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.86649412 |
| 53 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.85806668 |
| 54 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.85540903 |
| 55 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.83585022 |
| 56 | mast cell activation involved in immune response (GO:0002279) | 2.83495900 |
| 57 | mast cell degranulation (GO:0043303) | 2.83495900 |
| 58 | myeloid dendritic cell activation (GO:0001773) | 2.82837041 |
| 59 | negative regulation of interleukin-12 production (GO:0032695) | 2.81824595 |
| 60 | positive regulation of mast cell activation (GO:0033005) | 2.81338802 |
| 61 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.80995293 |
| 62 | response to peptidoglycan (GO:0032494) | 2.79584804 |
| 63 | positive T cell selection (GO:0043368) | 2.79243167 |
| 64 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.78124740 |
| 65 | negative thymic T cell selection (GO:0045060) | 2.77746037 |
| 66 | mature B cell differentiation involved in immune response (GO:0002313) | 2.77555472 |
| 67 | positive regulation of B cell differentiation (GO:0045579) | 2.77279189 |
| 68 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.74162536 |
| 69 | neutrophil activation (GO:0042119) | 2.73705008 |
| 70 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.73560817 |
| 71 | peptide catabolic process (GO:0043171) | 2.73275513 |
| 72 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.72693182 |
| 73 | regulation of B cell apoptotic process (GO:0002902) | 2.71675520 |
| 74 | detection of external biotic stimulus (GO:0098581) | 2.71611870 |
| 75 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.71051308 |
| 76 | regulation of gamma-delta T cell activation (GO:0046643) | 2.70037376 |
| 77 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.69447319 |
| 78 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.68238025 |
| 79 | T cell receptor signaling pathway (GO:0050852) | 2.68171312 |
| 80 | regulation of mast cell degranulation (GO:0043304) | 2.67987932 |
| 81 | regulation of T cell tolerance induction (GO:0002664) | 2.66808208 |
| 82 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.66052069 |
| 83 | cellular response to interferon-beta (GO:0035458) | 2.64471210 |
| 84 | T cell migration (GO:0072678) | 2.63962296 |
| 85 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.63455689 |
| 86 | natural killer cell activation involved in immune response (GO:0002323) | 2.61875679 |
| 87 | positive regulation of T cell activation (GO:0050870) | 2.61134081 |
| 88 | cytidine metabolic process (GO:0046087) | 2.60737196 |
| 89 | cytidine catabolic process (GO:0006216) | 2.60737196 |
| 90 | cytidine deamination (GO:0009972) | 2.60737196 |
| 91 | positive regulation of interleukin-12 production (GO:0032735) | 2.60393420 |
| 92 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.59194306 |
| 93 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.59093548 |
| 94 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.58977152 |
| 95 | negative regulation of cell killing (GO:0031342) | 2.58977152 |
| 96 | regulation of interleukin-10 production (GO:0032653) | 2.57070068 |
| 97 | positive regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.56679286 |
| 98 | positive regulation of T cell proliferation (GO:0042102) | 2.55135603 |
| 99 | granulocyte activation (GO:0036230) | 2.54628338 |
| 100 | adaptive immune response (GO:0002250) | 2.54010190 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.83148305 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.60689450 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.52955130 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.17673153 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.87385698 |
| 6 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.00886321 |
| 7 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.00350383 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.74805785 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.58663317 |
| 10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.54757974 |
| 11 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.50824710 |
| 12 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.45911542 |
| 13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.41001613 |
| 14 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.37922982 |
| 15 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.36524286 |
| 16 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.33792737 |
| 17 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.26123883 |
| 18 | MYB_26560356_Chip-Seq_TH2_Human | 2.16556625 |
| 19 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.14000775 |
| 20 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.09847680 |
| 21 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.99823970 |
| 22 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.93013670 |
| 23 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89058138 |
| 24 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.86130000 |
| 25 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.83937828 |
| 26 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80708780 |
| 27 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.77745165 |
| 28 | GATA3_26560356_Chip-Seq_TH2_Human | 1.76739320 |
| 29 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.70357853 |
| 30 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.69764071 |
| 31 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.67344522 |
| 32 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.64972612 |
| 33 | MYB_26560356_Chip-Seq_TH1_Human | 1.64791810 |
| 34 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.60811493 |
| 35 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.58606003 |
| 36 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.53896857 |
| 37 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.53500304 |
| 38 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.51127266 |
| 39 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.49788947 |
| 40 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.49116191 |
| 41 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.46894684 |
| 42 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.45387269 |
| 43 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.44121588 |
| 44 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.41922382 |
| 45 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.38846202 |
| 46 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.37980506 |
| 47 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.37456205 |
| 48 | SPI1_23127762_ChIP-Seq_K562_Human | 1.35731129 |
| 49 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.34645353 |
| 50 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34538683 |
| 51 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.31544586 |
| 52 | GATA1_22025678_ChIP-Seq_K562_Human | 1.29682241 |
| 53 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26492861 |
| 54 | MAF_26560356_Chip-Seq_TH1_Human | 1.24943861 |
| 55 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24680096 |
| 56 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.23033270 |
| 57 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.21320286 |
| 58 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.18897149 |
| 59 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.18373573 |
| 60 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.15849765 |
| 61 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.14740317 |
| 62 | P300_27268052_Chip-Seq_Bcells_Human | 1.14614148 |
| 63 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.14120547 |
| 64 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.13832622 |
| 65 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.13308395 |
| 66 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.12660480 |
| 67 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.12203470 |
| 68 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.10485518 |
| 69 | UTX_26944678_Chip-Seq_JUKART_Human | 1.09938419 |
| 70 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09591963 |
| 71 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04272564 |
| 72 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04086846 |
| 73 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.02028686 |
| 74 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01879182 |
| 75 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00885387 |
| 76 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98952267 |
| 77 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.98101705 |
| 78 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.97597423 |
| 79 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.96690760 |
| 80 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.96527556 |
| 81 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.94614417 |
| 82 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.94548900 |
| 83 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.93701730 |
| 84 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92686094 |
| 85 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90499893 |
| 86 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90419109 |
| 87 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90353802 |
| 88 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.89557359 |
| 89 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.87295503 |
| 90 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.87084796 |
| 91 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.86234483 |
| 92 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.86066562 |
| 93 | MYC_22102868_ChIP-Seq_BL_Human | 0.85746956 |
| 94 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.85742825 |
| 95 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.84270640 |
| 96 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.83791411 |
| 97 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.83696334 |
| 98 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.83438743 |
| 99 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.83005900 |
| 100 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.81830128 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.89672719 |
| 2 | MP0005671_abnormal_response_to | 3.72332266 |
| 3 | MP0003724_increased_susceptibility_to | 3.52421730 |
| 4 | MP0000685_abnormal_immune_system | 3.18956831 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 3.08789099 |
| 6 | MP0001800_abnormal_humoral_immune | 3.05782426 |
| 7 | MP0001790_abnormal_immune_system | 3.01917580 |
| 8 | MP0005387_immune_system_phenotype | 3.01917580 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.99058712 |
| 10 | MP0003436_decreased_susceptibility_to | 2.94735139 |
| 11 | MP0002139_abnormal_hepatobiliary_system | 2.84716261 |
| 12 | MP0009785_altered_susceptibility_to | 2.79670904 |
| 13 | MP0009840_abnormal_foam_cell | 2.67854029 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.62310886 |
| 15 | MP0002138_abnormal_hepatobiliary_system | 2.53423333 |
| 16 | MP0002723_abnormal_immune_serum | 2.52338469 |
| 17 | MP0003806_abnormal_nucleotide_metabolis | 2.50212979 |
| 18 | MP0005025_abnormal_response_to | 2.38040676 |
| 19 | MP0003303_peritoneal_inflammation | 2.36827051 |
| 20 | MP0002419_abnormal_innate_immunity | 2.36257214 |
| 21 | MP0002420_abnormal_adaptive_immunity | 2.29331274 |
| 22 | MP0001819_abnormal_immune_cell | 2.27759651 |
| 23 | MP0006082_CNS_inflammation | 2.18167278 |
| 24 | MP0005058_abnormal_lysosome_morphology | 2.15467848 |
| 25 | MP0002166_altered_tumor_susceptibility | 2.03758229 |
| 26 | MP0010155_abnormal_intestine_physiology | 2.03582371 |
| 27 | MP0009764_decreased_sensitivity_to | 1.90464946 |
| 28 | MP0005464_abnormal_platelet_physiology | 1.82701895 |
| 29 | MP0000716_abnormal_immune_system | 1.72207353 |
| 30 | MP0001845_abnormal_inflammatory_respons | 1.69904383 |
| 31 | MP0002398_abnormal_bone_marrow | 1.67762713 |
| 32 | MP0005360_urolithiasis | 1.62590357 |
| 33 | MP0001533_abnormal_skeleton_physiology | 1.60031293 |
| 34 | MP0002006_tumorigenesis | 1.54693636 |
| 35 | MP0003763_abnormal_thymus_physiology | 1.52705692 |
| 36 | MP0003183_abnormal_peptide_metabolism | 1.52658433 |
| 37 | MP0009333_abnormal_splenocyte_physiolog | 1.49398794 |
| 38 | MP0000689_abnormal_spleen_morphology | 1.44536720 |
| 39 | MP0005075_abnormal_melanosome_morpholog | 1.43358555 |
| 40 | MP0002429_abnormal_blood_cell | 1.43327988 |
| 41 | MP0000465_gastrointestinal_hemorrhage | 1.41145856 |
| 42 | MP0001853_heart_inflammation | 1.40509622 |
| 43 | MP0002405_respiratory_system_inflammati | 1.37644266 |
| 44 | MP0008469_abnormal_protein_level | 1.37586327 |
| 45 | MP0005167_abnormal_blood-brain_barrier | 1.36570197 |
| 46 | MP0005310_abnormal_salivary_gland | 1.32269406 |
| 47 | MP0003866_abnormal_defecation | 1.31489438 |
| 48 | MP0005397_hematopoietic_system_phenotyp | 1.29275819 |
| 49 | MP0001545_abnormal_hematopoietic_system | 1.29275819 |
| 50 | MP0003075_altered_response_to | 1.27277424 |
| 51 | MP0003191_abnormal_cellular_cholesterol | 1.24036872 |
| 52 | MP0004947_skin_inflammation | 1.22574781 |
| 53 | MP0002722_abnormal_immune_system | 1.21676952 |
| 54 | MP0009278_abnormal_bone_marrow | 1.20138567 |
| 55 | MP0008875_abnormal_xenobiotic_pharmacok | 1.16824920 |
| 56 | MP0006036_abnormal_mitochondrial_physio | 1.15855548 |
| 57 | MP0001873_stomach_inflammation | 1.12791271 |
| 58 | MP0002876_abnormal_thyroid_physiology | 1.10212323 |
| 59 | MP0003172_abnormal_lysosome_physiology | 1.10079839 |
| 60 | MP0008004_abnormal_stomach_pH | 1.01776932 |
| 61 | MP0003646_muscle_fatigue | 1.00320767 |
| 62 | MP0005166_decreased_susceptibility_to | 0.99792775 |
| 63 | MP0005365_abnormal_bile_salt | 0.96502981 |
| 64 | MP0002998_abnormal_bone_remodeling | 0.93115609 |
| 65 | MP0005085_abnormal_gallbladder_physiolo | 0.90378392 |
| 66 | MP0000858_altered_metastatic_potential | 0.89482364 |
| 67 | MP0003300_gastrointestinal_ulcer | 0.86620578 |
| 68 | MP0009643_abnormal_urine_homeostasis | 0.84980363 |
| 69 | MP0008872_abnormal_physiological_respon | 0.84192010 |
| 70 | MP0000371_diluted_coat_color | 0.83629918 |
| 71 | MP0000343_altered_response_to | 0.81819733 |
| 72 | MP0001666_abnormal_nutrient_absorption | 0.79257955 |
| 73 | MP0000490_abnormal_crypts_of | 0.78160240 |
| 74 | MP0001764_abnormal_homeostasis | 0.76660655 |
| 75 | MP0001663_abnormal_digestive_system | 0.76638354 |
| 76 | MP0005174_abnormal_tail_pigmentation | 0.75583067 |
| 77 | MP0000015_abnormal_ear_pigmentation | 0.74838718 |
| 78 | MP0009763_increased_sensitivity_to | 0.74565023 |
| 79 | MP0005165_increased_susceptibility_to | 0.73288148 |
| 80 | MP0002136_abnormal_kidney_physiology | 0.72237597 |
| 81 | MP0000249_abnormal_blood_vessel | 0.72053942 |
| 82 | MP0000703_abnormal_thymus_morphology | 0.70330217 |
| 83 | MP0004782_abnormal_surfactant_physiolog | 0.69891312 |
| 84 | MP0004147_increased_porphyrin_level | 0.68598372 |
| 85 | MP0006035_abnormal_mitochondrial_morpho | 0.67952148 |
| 86 | MP0003186_abnormal_redox_activity | 0.66272904 |
| 87 | MP0003448_altered_tumor_morphology | 0.64680197 |
| 88 | MP0004043_abnormal_pH_regulation | 0.64498114 |
| 89 | MP0005319_abnormal_enzyme/_coenzyme | 0.64149937 |
| 90 | MP0009765_abnormal_xenobiotic_induced | 0.63982949 |
| 91 | MP0005332_abnormal_amino_acid | 0.63425405 |
| 92 | MP0003195_calcinosis | 0.61673569 |
| 93 | MP0000372_irregular_coat_pigmentation | 0.60192435 |
| 94 | MP0005410_abnormal_fertilization | 0.58725064 |
| 95 | MP0002933_joint_inflammation | 0.58573250 |
| 96 | MP0002019_abnormal_tumor_incidence | 0.58526821 |
| 97 | MP0003786_premature_aging | 0.57546470 |
| 98 | MP0005636_abnormal_mineral_homeostasis | 0.56705711 |
| 99 | MP0002396_abnormal_hematopoietic_system | 0.56260824 |
| 100 | MP0004019_abnormal_vitamin_homeostasis | 0.55596038 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 4.07549856 |
| 2 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.74279286 |
| 3 | Meningitis (HP:0001287) | 3.68638508 |
| 4 | Abnormality of the prostate (HP:0008775) | 3.61166910 |
| 5 | Vasculitis (HP:0002633) | 3.48705018 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 3.42474502 |
| 7 | Mediastinal lymphadenopathy (HP:0100721) | 3.39551329 |
| 8 | Abnormality of macrophages (HP:0004311) | 3.29815350 |
| 9 | Gastrointestinal stroma tumor (HP:0100723) | 3.29529800 |
| 10 | IgG deficiency (HP:0004315) | 3.24961827 |
| 11 | Pulmonary infiltrates (HP:0002113) | 3.22069231 |
| 12 | Chronic obstructive pulmonary disease (HP:0006510) | 3.17250920 |
| 13 | Obstructive lung disease (HP:0006536) | 3.17250920 |
| 14 | Recurrent abscess formation (HP:0002722) | 3.15225846 |
| 15 | Panhypogammaglobulinemia (HP:0003139) | 3.14812209 |
| 16 | Abnormality of glycolipid metabolism (HP:0010969) | 3.12582628 |
| 17 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.12582628 |
| 18 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.12582628 |
| 19 | Recurrent fungal infections (HP:0002841) | 3.11815537 |
| 20 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.09323420 |
| 21 | Myositis (HP:0100614) | 3.04303273 |
| 22 | Vacuolated lymphocytes (HP:0001922) | 3.01495203 |
| 23 | Stomatitis (HP:0010280) | 2.99839912 |
| 24 | Eczematoid dermatitis (HP:0000976) | 2.99594438 |
| 25 | Optic neuritis (HP:0100653) | 2.98482370 |
| 26 | Retrobulbar optic neuritis (HP:0100654) | 2.98482370 |
| 27 | Systemic lupus erythematosus (HP:0002725) | 2.93269754 |
| 28 | Urticaria (HP:0001025) | 2.87621083 |
| 29 | Recurrent bronchitis (HP:0002837) | 2.85234343 |
| 30 | Recurrent viral infections (HP:0004429) | 2.83943957 |
| 31 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.79364197 |
| 32 | Recurrent cutaneous fungal infections (HP:0011370) | 2.79364197 |
| 33 | Orchitis (HP:0100796) | 2.78160571 |
| 34 | Abnormality of B cell number (HP:0010975) | 2.74780163 |
| 35 | Hemoptysis (HP:0002105) | 2.69250891 |
| 36 | 3-Methylglutaconic aciduria (HP:0003535) | 2.68377468 |
| 37 | Recurrent sinusitis (HP:0011108) | 2.68376172 |
| 38 | Recurrent skin infections (HP:0001581) | 2.61411348 |
| 39 | Pulmonary fibrosis (HP:0002206) | 2.60482458 |
| 40 | Autoimmune thrombocytopenia (HP:0001973) | 2.60405808 |
| 41 | Chest pain (HP:0100749) | 2.58102826 |
| 42 | Abnormality of T cell physiology (HP:0011840) | 2.51688195 |
| 43 | Pustule (HP:0200039) | 2.49224135 |
| 44 | Osteomyelitis (HP:0002754) | 2.48017761 |
| 45 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.47871044 |
| 46 | Dysostosis multiplex (HP:0000943) | 2.46996012 |
| 47 | Eosinophilia (HP:0001880) | 2.44436913 |
| 48 | IgM deficiency (HP:0002850) | 2.43243945 |
| 49 | Encephalitis (HP:0002383) | 2.40588757 |
| 50 | Increased serum ferritin (HP:0003281) | 2.38695680 |
| 51 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.38293930 |
| 52 | Chronic diarrhea (HP:0002028) | 2.37067883 |
| 53 | Xerostomia (HP:0000217) | 2.36869144 |
| 54 | Abnormality of T cells (HP:0002843) | 2.36827391 |
| 55 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.35900352 |
| 56 | Skin rash (HP:0000988) | 2.33837620 |
| 57 | Granulocytopenia (HP:0001913) | 2.33780107 |
| 58 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.33754449 |
| 59 | Microvesicular hepatic steatosis (HP:0001414) | 2.32768131 |
| 60 | Abnormality of the pleura (HP:0002103) | 2.31505252 |
| 61 | Chronic otitis media (HP:0000389) | 2.31494663 |
| 62 | Prostate neoplasm (HP:0100787) | 2.30917932 |
| 63 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.29047013 |
| 64 | Stomach cancer (HP:0012126) | 2.28010628 |
| 65 | Restrictive lung disease (HP:0002091) | 2.27307401 |
| 66 | IgA deficiency (HP:0002720) | 2.25186405 |
| 67 | B lymphocytopenia (HP:0010976) | 2.25003741 |
| 68 | Recurrent pneumonia (HP:0006532) | 2.24625021 |
| 69 | Increased cerebral lipofuscin (HP:0011813) | 2.23926581 |
| 70 | Hypertensive crisis (HP:0100735) | 2.22484952 |
| 71 | Lymphopenia (HP:0001888) | 2.22076155 |
| 72 | Abnormality of iron homeostasis (HP:0011031) | 2.21125523 |
| 73 | Lipid accumulation in hepatocytes (HP:0006561) | 2.17047526 |
| 74 | Polyneuropathy (HP:0001271) | 2.16692867 |
| 75 | Gangrene (HP:0100758) | 2.16534773 |
| 76 | Petechiae (HP:0000967) | 2.15202488 |
| 77 | Cellulitis (HP:0100658) | 2.15133832 |
| 78 | Arthralgia (HP:0002829) | 2.14596242 |
| 79 | Abnormality of T cell number (HP:0011839) | 2.13104404 |
| 80 | Increased hepatocellular lipid droplets (HP:0006565) | 2.10602030 |
| 81 | Verrucae (HP:0200043) | 2.09334778 |
| 82 | Papilloma (HP:0012740) | 2.09334778 |
| 83 | Keratoconjunctivitis (HP:0001096) | 2.09206345 |
| 84 | Exertional dyspnea (HP:0002875) | 2.09106856 |
| 85 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.07901380 |
| 86 | Joint swelling (HP:0001386) | 2.03618928 |
| 87 | Chronic sinusitis (HP:0011109) | 2.02616874 |
| 88 | Abnormality of eosinophils (HP:0001879) | 2.02305589 |
| 89 | Keratoconjunctivitis sicca (HP:0001097) | 2.01643975 |
| 90 | Recurrent lower respiratory tract infections (HP:0002783) | 2.01030431 |
| 91 | Hepatocellular necrosis (HP:0001404) | 2.00999406 |
| 92 | Gastrointestinal infarctions (HP:0005244) | 2.00483957 |
| 93 | Leukocytosis (HP:0001974) | 1.98902957 |
| 94 | Arterial thrombosis (HP:0004420) | 1.98888572 |
| 95 | Neutropenia (HP:0001875) | 1.98573372 |
| 96 | Epistaxis (HP:0000421) | 1.98256340 |
| 97 | Increased intramyocellular lipid droplets (HP:0012240) | 1.97454407 |
| 98 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.97448843 |
| 99 | Mitochondrial inheritance (HP:0001427) | 1.97422394 |
| 100 | Pulmonary embolism (HP:0002204) | 1.94564003 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 3.64229364 |
| 2 | TLK1 | 3.14956662 |
| 3 | KIT | 3.11586806 |
| 4 | TXK | 3.07098637 |
| 5 | MAP4K1 | 2.86284549 |
| 6 | BMPR2 | 2.76120548 |
| 7 | RIPK4 | 2.72921320 |
| 8 | CSF1R | 2.49525228 |
| 9 | IKBKB | 2.19641566 |
| 10 | TIE1 | 2.19163496 |
| 11 | SYK | 2.19121252 |
| 12 | MAP3K14 | 2.16261754 |
| 13 | MST4 | 2.00672092 |
| 14 | TBK1 | 1.97724340 |
| 15 | EIF2AK3 | 1.94083166 |
| 16 | BLK | 1.88494897 |
| 17 | TEC | 1.87414229 |
| 18 | OXSR1 | 1.83965701 |
| 19 | IKBKE | 1.80440168 |
| 20 | JAK3 | 1.74144904 |
| 21 | FES | 1.70432577 |
| 22 | ZAK | 1.68408178 |
| 23 | PINK1 | 1.68157576 |
| 24 | GRK6 | 1.65469578 |
| 25 | BTK | 1.62862252 |
| 26 | BCKDK | 1.59646780 |
| 27 | MATK | 1.57634521 |
| 28 | LYN | 1.56006373 |
| 29 | MAP3K12 | 1.55082145 |
| 30 | KDR | 1.54576202 |
| 31 | TYK2 | 1.50788229 |
| 32 | VRK2 | 1.44827012 |
| 33 | ERN1 | 1.43511468 |
| 34 | ITK | 1.39895650 |
| 35 | GRK1 | 1.39403070 |
| 36 | EIF2AK1 | 1.36149496 |
| 37 | CDK19 | 1.33074439 |
| 38 | IRAK4 | 1.30925506 |
| 39 | PIK3CG | 1.28076169 |
| 40 | NME2 | 1.22414444 |
| 41 | JAK1 | 1.19956537 |
| 42 | CSK | 1.19522469 |
| 43 | NUAK1 | 1.16758558 |
| 44 | VRK1 | 1.13507943 |
| 45 | ADRBK2 | 1.11063699 |
| 46 | STK16 | 1.08583630 |
| 47 | LCK | 1.07166153 |
| 48 | DAPK1 | 1.06500007 |
| 49 | GRK7 | 1.06395685 |
| 50 | TESK2 | 0.99500040 |
| 51 | HCK | 0.97811253 |
| 52 | BMPR1B | 0.90958801 |
| 53 | DAPK3 | 0.90350951 |
| 54 | CHUK | 0.84632214 |
| 55 | PRKCQ | 0.80939082 |
| 56 | ZAP70 | 0.79317513 |
| 57 | MAP2K2 | 0.78058948 |
| 58 | MAPKAPK3 | 0.77793778 |
| 59 | STK10 | 0.77058764 |
| 60 | RPS6KA5 | 0.76591673 |
| 61 | MAPK11 | 0.76227011 |
| 62 | TRPM7 | 0.75861899 |
| 63 | STK39 | 0.74456234 |
| 64 | JAK2 | 0.70266791 |
| 65 | TGFBR2 | 0.69876531 |
| 66 | FGR | 0.69847093 |
| 67 | EIF2AK2 | 0.67814962 |
| 68 | ABL1 | 0.66557097 |
| 69 | IGF1R | 0.65511424 |
| 70 | TNK2 | 0.61842082 |
| 71 | PIM1 | 0.61236061 |
| 72 | ACVR1B | 0.58756327 |
| 73 | WNK4 | 0.56857552 |
| 74 | DAPK2 | 0.54647678 |
| 75 | FLT3 | 0.54028086 |
| 76 | PRKG2 | 0.51901664 |
| 77 | CDK8 | 0.50900695 |
| 78 | PIM2 | 0.50144815 |
| 79 | PDK2 | 0.49842004 |
| 80 | MARK3 | 0.49038834 |
| 81 | MYLK | 0.48149957 |
| 82 | GRK5 | 0.48127922 |
| 83 | PRKCD | 0.46222476 |
| 84 | CCNB1 | 0.44006141 |
| 85 | MAPKAPK5 | 0.43600710 |
| 86 | MUSK | 0.39043632 |
| 87 | EGFR | 0.38574755 |
| 88 | MAP3K13 | 0.37778892 |
| 89 | TGFBR1 | 0.37561301 |
| 90 | FRK | 0.35292149 |
| 91 | PDK1 | 0.34304670 |
| 92 | INSRR | 0.33245720 |
| 93 | PTK2B | 0.32207422 |
| 94 | CDK9 | 0.28618787 |
| 95 | PRKCI | 0.28557557 |
| 96 | MAPKAPK2 | 0.27311504 |
| 97 | ABL2 | 0.25644064 |
| 98 | FER | 0.25426350 |
| 99 | MAP2K6 | 0.24979973 |
| 100 | INSR | 0.24906666 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Asthma_Homo sapiens_hsa05310 | 5.78157473 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 5.16615010 |
| 3 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 4.82259374 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.80708695 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 4.80222032 |
| 6 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 4.11836768 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.41980704 |
| 8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.03453656 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 3.03302892 |
| 10 | Viral myocarditis_Homo sapiens_hsa05416 | 2.76746299 |
| 11 | Leishmaniasis_Homo sapiens_hsa05140 | 2.68956403 |
| 12 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.57554603 |
| 13 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.83721940 |
| 14 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.80608755 |
| 15 | Tuberculosis_Homo sapiens_hsa05152 | 1.42055643 |
| 16 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.40544258 |
| 17 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.38031542 |
| 18 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.34824137 |
| 19 | Other glycan degradation_Homo sapiens_hsa00511 | 1.30368421 |
| 20 | Influenza A_Homo sapiens_hsa05164 | 1.28065637 |
| 21 | Proteasome_Homo sapiens_hsa03050 | 1.23277155 |
| 22 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.16274945 |
| 23 | Phagosome_Homo sapiens_hsa04145 | 1.08164048 |
| 24 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.03309481 |
| 25 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.99467398 |
| 26 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.94875768 |
| 27 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.88313485 |
| 28 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.81990477 |
| 29 | Lysosome_Homo sapiens_hsa04142 | 0.79810427 |
| 30 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.75126636 |
| 31 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.74689624 |
| 32 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.74111034 |
| 33 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.73784997 |
| 34 | Legionellosis_Homo sapiens_hsa05134 | 0.71606353 |
| 35 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.63555959 |
| 36 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.62179848 |
| 37 | Pertussis_Homo sapiens_hsa05133 | 0.59680910 |
| 38 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.56937194 |
| 39 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.56369589 |
| 40 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.53182086 |
| 41 | Measles_Homo sapiens_hsa05162 | 0.52386467 |
| 42 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.50199515 |
| 43 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.49457964 |
| 44 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.48292748 |
| 45 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.47506563 |
| 46 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.47131832 |
| 47 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.47081693 |
| 48 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.45018198 |
| 49 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.43532628 |
| 50 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.42442806 |
| 51 | Mineral absorption_Homo sapiens_hsa04978 | 0.41099062 |
| 52 | Malaria_Homo sapiens_hsa05144 | 0.39667753 |
| 53 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.39098035 |
| 54 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.38527554 |
| 55 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.38272063 |
| 56 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.33730057 |
| 57 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.33627703 |
| 58 | HTLV-I infection_Homo sapiens_hsa05166 | 0.32960319 |
| 59 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.31540953 |
| 60 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.30823585 |
| 61 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.28023009 |
| 62 | Parkinsons disease_Homo sapiens_hsa05012 | 0.27102368 |
| 63 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.26937169 |
| 64 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.26302659 |
| 65 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.25843715 |
| 66 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.25726052 |
| 67 | Shigellosis_Homo sapiens_hsa05131 | 0.24813773 |
| 68 | Salmonella infection_Homo sapiens_hsa05132 | 0.22452702 |
| 69 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.19261397 |
| 70 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.18425305 |
| 71 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.17897646 |
| 72 | Protein export_Homo sapiens_hsa03060 | 0.17797558 |
| 73 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.16707616 |
| 74 | Phototransduction_Homo sapiens_hsa04744 | 0.16684336 |
| 75 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.15712690 |
| 76 | RNA degradation_Homo sapiens_hsa03018 | 0.14606360 |
| 77 | Apoptosis_Homo sapiens_hsa04210 | 0.13502959 |
| 78 | Hepatitis C_Homo sapiens_hsa05160 | 0.13392221 |
| 79 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.13287046 |
| 80 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.12901513 |
| 81 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.12458419 |
| 82 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.12109077 |
| 83 | Peroxisome_Homo sapiens_hsa04146 | 0.10607561 |
| 84 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.10038814 |
| 85 | Platelet activation_Homo sapiens_hsa04611 | 0.09070256 |
| 86 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.08761802 |
| 87 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.07771689 |
| 88 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.06704063 |
| 89 | Ribosome_Homo sapiens_hsa03010 | 0.06251885 |
| 90 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.06135356 |
| 91 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.05337491 |
| 92 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.05253187 |
| 93 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.04676467 |
| 94 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.04476530 |
| 95 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.04467181 |
| 96 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.03957360 |
| 97 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.03576942 |
| 98 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.02467984 |
| 99 | Hepatitis B_Homo sapiens_hsa05161 | 0.02306008 |
| 100 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.01986722 |

